United States · Nanotechnology startup

Exogenesis

Exogenesis Corporation is engaged in developing and processing implantable vascular stents, orthopedic devices and other related products.

Funding reportedLast round: Undisclosed round

NanotechnologyBillerica, United States

What company datasets say Exogenesis raised

Funding, as reported

Reported in all$7.8Min dollars
Rounds2
Last roundUndisclosed round
Last round dateDec 2010
Investors listed3
SEC Form D$11M sold, 3 filings, last Nov 2010

On a portfolio page

Investors who name them

Each firm lists Exogenesis on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Nanotechnology in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Exogenesis in front of investors. Or tell us what we have wrong.